Search Results for 'treatment of intracranial atherosclerotic disease'

1 results found.

Galway medical device firm raises €6.4m to develop stroke treatment

image preview

Galway medical device company Ceroflo has closed out an investment round which has raised €6.4m to advance its disruptive technology to revolutionise the treatment of intracranial atherosclerotic disease (ICAD), a leading cause of stroke.

 

Page generated in 0.0342 seconds.